Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The influence of renin-angiotensin system genotypes on the antiproteinuric response to high doses of olmesartan in non-diabetic proteinuric nephropathies.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - 13 Nov 2013

Goyache-Goñi Begoña, Aranda-Lara Pedro, Reyes-Engels Armando, Frutos-Sanz Miguel A, Hernández-Marrero Domingo

Abstract excerpt

OBJECTIVE: To assess the antiproteinuric response to multifactorial treatment based on high doses of angiotensin II receptor antagonists (ARBs) (olmesartan) in patients with non-diabetic proteinuric nephropathies, according to three renin-angiotensin system (RAS) polymorphisms: insertion/deletion of the angiotensin converting enzyme (ACE) gene, the angiotensinogen gene M235T and the angiotensin II type 1 receptor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin Receptor Antagonists
Share to Antihypertensive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Imidazoles

Share to Proteinuria

Share to Renal Insufficiency, Chronic

Share to Renin-Angiotensin System

Share to Tetrazoles

Source

Identifiers

PMID: 24241364
DOI: 10.3265/Nefrologia.pre2013.Sep.12258

Genes

ACE

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The influence of renin-angiotensin system genotypes on the antiproteinuric response to high doses of olmesartan in non-diabetic proteinuric nephropathies.PMID 24241364Read ↗

[Pharmacogenetics of angiotensin system in non diabetic nephropathy].Semantic proximity Read ↗

Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.Semantic proximity Read ↗

Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.Semantic proximity Read ↗

Renin^|^ndash;Angiotensin System, Hypertension, and Chronic Kidney Disease: Pharmacogenetic ImplicationsSemantic proximity Read ↗

Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.Semantic proximity Read ↗

Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.Semantic proximity Read ↗

Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?Semantic proximity Read ↗

Genetic variant of the Renin-Angiotensin system and diabetes influences blood pressure response to Angiotensin receptor blockers.Semantic proximity Read ↗

Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome.Semantic proximity Read ↗

The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk.Semantic proximity Read ↗

Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.Semantic proximity Read ↗

Renin–angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.